AR130700A2 - GRAPIPRANT COMPOSITIONS AND METHODS OF USE - Google Patents
GRAPIPRANT COMPOSITIONS AND METHODS OF USEInfo
- Publication number
- AR130700A2 AR130700A2 ARP230102678A ARP230102678A AR130700A2 AR 130700 A2 AR130700 A2 AR 130700A2 AR P230102678 A ARP230102678 A AR P230102678A AR P230102678 A ARP230102678 A AR P230102678A AR 130700 A2 AR130700 A2 AR 130700A2
- Authority
- AR
- Argentina
- Prior art keywords
- grapiprant
- human animal
- compositions
- methods
- inflammation
- Prior art date
Links
- HZVLFTCYCLXTGV-UHFFFAOYSA-N 1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea Chemical compound CCC1=NC2=C(C)N=C(C)C=C2N1C(C=C1)=CC=C1CCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 HZVLFTCYCLXTGV-UHFFFAOYSA-N 0.000 title abstract 3
- 229950004517 grapiprant Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente descripción proporciona un método para el tratamiento del dolor o la inflamación en un animal no humano en necesidad del mismo. El método comprende la administración a un animal no humano de una composición farmacéutica que comprende una cantidad terapéuticamente eficaz de grapiprant. También se proporcionan en el presente documento composiciones farmacéuticas para el tratamiento del dolor o la inflamación en un animal no humano en necesidad del mismo. Las composiciones farmacéuticas comprenden una cantidad terapéuticamente eficaz de grapiprant y un excipiente, incluyendo saborizantes.The present disclosure provides a method for the treatment of pain or inflammation in a non-human animal in need thereof. The method comprises administering to a non-human animal a pharmaceutical composition comprising a therapeutically effective amount of grapiprant. Also provided herein are pharmaceutical compositions for the treatment of pain or inflammation in a non-human animal in need thereof. The pharmaceutical compositions comprise a therapeutically effective amount of grapiprant and an excipient, including flavorings.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461948957P | 2014-03-06 | 2014-03-06 | |
| US202062089713P | 2020-12-09 | 2020-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR130700A2 true AR130700A2 (en) | 2025-01-08 |
Family
ID=94475437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230102678A AR130700A2 (en) | 2014-03-06 | 2023-10-05 | GRAPIPRANT COMPOSITIONS AND METHODS OF USE |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR130700A2 (en) |
-
2023
- 2023-10-05 AR ARP230102678A patent/AR130700A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019006291A2 (en) | Amino acid compositions and methods of treatment of liver diseases | |
| MX366317B (en) | COMPOSITIONS AND METHODS TO TREAT CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES. | |
| CO2019006292A2 (en) | Amino acid compositions and methods for the treatment of diseases and muscular disorders | |
| CR20160200A (en) | COMBINATIONS OF HISTONE DEACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS | |
| NI201600071A (en) | AUTOTAXIN INHIBITOR COMPOUNDS | |
| MX2016011810A (en) | Pharmaceutical compositions of therapeutically active compounds. | |
| MX2015009045A (en) | COMPOSITIONS AND METHODS TO TREAT SEVERE PAIN. | |
| EA201790398A1 (en) | METHODS OF TREATING LIVER DISEASES | |
| MX2015009104A (en) | COMPOSITIONS IN SOLID SOLUTION AND USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES. | |
| MX2017006113A (en) | Novel polymeric hgh prodrugs. | |
| EA201691808A1 (en) | CORTICOSTEROID COMPOSITIONS FOR LOCAL APPLICATION | |
| BR112018005905A2 (en) | ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound? | |
| MX2019009783A (en) | METHOD TO MANUFACTURE A BAR THAT INCLUDES ANTI-TRANSPIRANT. | |
| CO7141430A2 (en) | Vesicular formulations for use in the treatment of pain or reduced mobility of a joint | |
| NI201600070A (en) | AUTOTAXIN TETRAYCLIC INHIBITORS | |
| MX2017000764A (en) | Aqueous formulation comprising paracetamol and ibuprofen. | |
| MX2016015437A (en) | COMBINATION THAT INCLUDES A GLUCOCORTICOID AND EDO-S101. | |
| BR112018069682A2 (en) | treatment methods for cholestatic and fibrotic diseases | |
| MX2018005628A (en) | Treatments of accumulated fat with deoxycholic acid and salts thereof. | |
| MX2018012230A (en) | METHODS TO TREAT EYE DISEASES. | |
| MX2016011025A (en) | GRAPIPRANT COMPOSITIONS AND METHODS TO USE THE SAME. | |
| ECSP16086247A (en) | (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| PH12016500910A1 (en) | Long-acting ketoprofen compositions | |
| ECSP16086232A (en) | (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| AR130700A2 (en) | GRAPIPRANT COMPOSITIONS AND METHODS OF USE |